For example, evidence in breast cancer cell lines suggests that GRB7 may be involved in proliferation and that inhibiting both HER2 and GRB7 may enhance the inhibitory effect on cell growth (Pero et al, 2007). Here, ERBB2 is linked to breast cancer.